TRLV - Trulieve Cannabis Corp.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$15.00
DETAILS
HIGH:
$15.00
LOW:
$15.00
MEDIAN:
$15.00
CONSENSUS:
$15.00
UPSIDE:
37.43%
| Metric | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | 271.0 | 286.8 | 293.1 | 288.2 | 302.1 |
| Cost of Revenue | 108.7 | 116.7 | 118.0 | 118.3 | 119.2 |
| Gross Profit | 162.3 | 170.1 | 175.2 | 169.9 | 182.9 |
| Operating Expenses | |||||
| R&D Expenses | 0 | 0 | 0 | 0 | 0 |
| SG&A Expenses | 101.8 | 104.9 | 126.3 | 99.0 | 101.1 |
| Other Expenses | 431.0 | 29.7 | 29.4 | 29.5 | 29.4 |
| Operating Expenses | 532.8 | 134.6 | 155.7 | 128.5 | 130.5 |
| Operating Income | |||||
| Operating Income | (370.5) | 35.4 | 19.4 | 41.4 | 52.4 |
| Interest Expense | 12.8 | 13.3 | 14.7 | 16.1 | 16.4 |
| Interest Income | 3.1 | 2.7 | 3.4 | 4.4 | 3.6 |
| Profitability | |||||
| EBITDA | (331.5) | 82.3 | 61.3 | 88.8 | 98.4 |
| EBIT | (370.6) | 38.5 | 17.6 | 45.4 | 55.3 |
| Income Before Tax | (383.4) | 25.2 | 2.9 | 29.3 | 38.9 |
| Income Tax Expense | 22.0 | 21.9 | 47.9 | 53.0 | 54.7 |
| Net Income | (406.1) | 2.4 | (42.9) | (26.8) | (13.8) |
| Per Share Data | |||||
| EPS (Basic) | -2.10 | 0.01 | -0.22 | -0.14 | -0.07 |
| EPS (Diluted) | -2.10 | 0.01 | -0.22 | -0.14 | -0.07 |
| Shares Outstanding | 192.7 | 192.5 | 191.7 | 191.2 | 191.2 |
| Metric | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 |
|---|---|---|---|---|---|
| Current Assets | |||||
| Cash & Cash Equivalents | 325.4 | 352.9 | 255.5 | 449.2 | 392.6 |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 27.1 | 22.1 | 20.2 | 19.4 | 21.2 |
| Inventory | 186.9 | 242.3 | 242.3 | 243.3 | 241.5 |
| Other Current Assets | 4.7 | 14.5 | 26.4 | 23.9 | 33.7 |
| Total Current Assets | 564.8 | 653.0 | 562.7 | 756.4 | 711.4 |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 724.9 | 852.0 | 838.7 | 865.6 | 881.1 |
| Goodwill | 325.6 | 483.9 | 483.9 | 483.9 | 483.9 |
| Intangible Assets | 300.4 | 780.8 | 798.4 | 815.3 | 832.4 |
| Long-Term Investments | 152.5 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 9.2 | 12.4 | 12.4 | 20.3 | 13.0 |
| Total Non-Current Assets | 1,512.6 | 2,129.0 | 2,133.4 | 2,185.2 | 2,210.5 |
| Total Assets | 2,077.4 | 2,781.9 | 2,696.1 | 2,941.6 | 2,921.8 |
| Current Liabilities | |||||
| Account Payables | 61.5 | 78.9 | 26.8 | 81.3 | 79.0 |
| Short-Term Debt | 4.2 | 4.1 | 4.1 | 3.7 | 3.7 |
| Deferred Revenue | 7.0 | 10.0 | 9.6 | 8.9 | 8.4 |
| Other Current Liabilities | 0.3 | 4.1 | 25.7 | 4.7 | 7.7 |
| Total Current Liabilities | 95.1 | 124.2 | 126.9 | 124.1 | 123.8 |
| Non-Current Liabilities | |||||
| Long-Term Debt | 285.2 | 285.7 | 227.6 | 473.8 | 474.2 |
| Deferred Tax Liabilities | 57.2 | 169.8 | 178.0 | 181.9 | 186.6 |
| Other Non-Current Liabilities | 608.2 | 741.2 | 714.8 | 665.5 | 606.9 |
| Total Non-Current Liabilities | 1,216.5 | 1,508.5 | 1,426.1 | 1,631.2 | 1,588.5 |
| Total Liabilities | 1,311.5 | 1,632.6 | 1,553.1 | 1,755.3 | 1,712.4 |
| Stockholders' Equity | |||||
| Common Stock | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | (1,315.7) | (909.7) | (912.1) | (869.2) | (842.4) |
| Accumulated Other Comprehensive Income | 0 | 0 | 0 | 0 | 0 |
| Total Stockholders' Equity | 767.5 | 1,167.8 | 1,161.2 | 1,203.8 | 1,225.0 |
| Total Liabilities & Equity | 2,077.4 | 2,781.9 | 2,696.1 | 2,941.6 | 2,921.8 |
| Debt Metrics | |||||
| Total Debt | 577.3 | 628.7 | 563.6 | 813.1 | 823.7 |
| Net Debt | 251.8 | 275.8 | 308.1 | 363.9 | 431.1 |
| Metric | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | (406.1) | 2.3 | (43.6) | (28.8) | (16.1) |
| Depreciation & Amortization | 39.1 | 43.7 | 43.7 | 43.4 | 43.1 |
| Stock-Based Compensation | 6.9 | 4.1 | 4.0 | 5.8 | 6.8 |
| Change in Working Capital | 11.8 | 10.9 | 51.6 | 54.8 | 46.1 |
| Other Non-Cash Items | 412.2 | 2.9 | 7.4 | 6.3 | 11.0 |
| Operating Cash Flow | 53.1 | 55.7 | 59.2 | 76.8 | 85.7 |
| Investing Activities | |||||
| Capital Expenditure | (21) | (13.5) | (7.0) | (16.5) | (16.2) |
| Acquisitions | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales/Maturities of Investments | 0 | 0 | 0 | (0.4) | 0.4 |
| Other Investing Activities | (53.9) | 0.3 | (2.5) | (2.7) | 2.9 |
| Investing Cash Flow | (74.9) | (13.2) | (5.9) | (15.4) | (8.2) |
| Financing Activities | |||||
| Net Debt Issuance | (1.7) | 58.7 | (385.9) | (2.0) | (3.6) |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (4) | (3.9) | 130.5 | (2.8) | (2.2) |
| Financing Cash Flow | (5.7) | 54.8 | (255.4) | (4.8) | (5.8) |
| Cash Position | |||||
| Net Change in Cash | (27.5) | 97.3 | (202.1) | 56.6 | 71.6 |
| Cash at Beginning | 352.9 | 255.5 | 457.6 | 401.0 | 329.4 |
| Cash at End | 325.4 | 352.9 | 255.5 | 457.6 | 401.0 |
| Free Cash Flow | 32.1 | 42.2 | 52.2 | 60.3 | 69.5 |
| Key Metrics | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 271.0 | 286.8 | 293.1 | 288.2 | 302.1 |
| Gross Profit | 162.3 | 170.1 | 175.2 | 169.9 | 182.9 |
| Operating Income | (370.5) | 35.4 | 19.4 | 41.4 | 52.4 |
| Net Income | (406.1) | 2.4 | (42.9) | (26.8) | (13.8) |
| EPS (Diluted) | -2.10 | 0.01 | -0.22 | -0.14 | -0.07 |
| Balance Sheet | |||||
| Cash & Equivalents | 325.4 | 352.9 | 255.5 | 449.2 | 392.6 |
| Total Assets | 2,077.4 | 2,781.9 | 2,696.1 | 2,941.6 | 2,921.8 |
| Total Debt | 577.3 | 628.7 | 563.6 | 813.1 | 823.7 |
| Stockholders' Equity | 767.5 | 1,167.8 | 1,161.2 | 1,203.8 | 1,225.0 |
| Cash Flow | |||||
| Operating Cash Flow | 53.1 | 55.7 | 59.2 | 76.8 | 85.7 |
| Capital Expenditure | (21) | (13.5) | (7.0) | (16.5) | (16.2) |
| Free Cash Flow | 32.1 | 42.2 | 52.2 | 60.3 | 69.5 |